Andere Sprachen Kits Eyecare Ltd.

Aktien

A2QSNP

CA49804N1042

KITS

Verzögert Toronto S.E. Andere Börsenplätze 19:22:42 26.04.2024			% 5 Tage	% 1. Jan.
5,95 ^CAD	+4,94 %		-2,46 %	-4,65 %

16.04.	KITS Eyecare Ltd. kündigt Ernennungen von Führungskräften an	CI
04.04.	Kits Eyecare meldet vorläufige Q1-Ergebnisse	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

KITS Eyecare Sets First Quarter 2024 Conference Call for Wednesday, May 8, 2024, at 9:00 a.m. ET	23.04.
KITS Eyecare Hires Two Key Senior Finance Leaders	16.04.
KITS Eyecare Ltd. Announces Executive Appointments	16.04.
Kits Eyecare Announces Sabrina Liak Will Transition to Senior Advisor Role and Continue as Board Member	10.04.
KITS Eyecare Announces Sabrina Liak will Transition to Senior Advisor Role and Continue as Board Member	10.04.
Kits Eyecare Reporting Preliminary Q1 Results	04.04.
KITS Eyecare Brief: Revenue Grew Approximately 23% YOY to Over $34 Million; Cash Position Remains Strong at Approximately $18 Million	04.04.
KITS Eyecare Brief: Reporting Preliminary First Quarter 2024 Results	04.04.
KITS Eyecare Reports Preliminary First Quarter 2024 Results	04.04.
KITS Eyecare to Present at the LD Micro Invitational XIV	02.04.
Kits Eyecare Promotes Zhe Choo to Chief Financial Officer Role	18.03.
KITS Eyecare Names Zhe Choo Chief Financial Officer	18.03.
KITS Eyecare Brief: Naming Zhe Choo Chief Financial Officer	18.03.
Kits Eyecare Ltd. Appoints Zhe Choo as Chief Financial Officer, Effective March 31, 2024	18.03.
KITS Eyecare to Participate in the 36th Annual ROTH Conference on March 18, 2024	12.03.
Kits Eyecar Narrows Q4 Loss, Revenue Grows	06.03.
Kits Eyecare Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	06.03.
KITS Eyecare Brief: Q4 Net loss improved to $0.5 million, or $(0.02) per share (basic), compared to a net loss of $1.4 million, or $(0.04) per share (basic), in the prior year period	06.03.
KITS Eyecare Brief: Q4 Revenue increased by 21% to a record $31.7 million compared to $26.2 million	06.03.
KITS Eyecare Reports Fourth Quarter and Full Year 2023 Results	06.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Kits Eyecare Ltd.

Aktien

A2QSNP

CA49804N1042

KITS

Andere Sprachen

Filter